首页> 外文期刊>Journal of Pharmacological and Toxicological Methods >Human embryonic stem cell derived cardiac myocytes detect hERG-mediated repolarization effects, but not Nav1.5 induced depolarization delay
【24h】

Human embryonic stem cell derived cardiac myocytes detect hERG-mediated repolarization effects, but not Nav1.5 induced depolarization delay

机译:人类胚胎干细胞衍生的心肌细胞可检测hERG介导的复极化作用,但不能检测Nav1.5诱导的复极化延迟

获取原文
获取原文并翻译 | 示例
       

摘要

Introduction: Cardiac safety is of paramount importance in contemporary drug development. Efficient and sensitive evaluation of cardiac safety in the research and development of new molecular agents begins with preclinical in-vitro models. A new model that is currently under evaluation is the human embryonic stem-cell derived cardiac myocytes (hESC-CM) (Peng, Lacerda, Kirsch, Brown, & Bruening-Wright, 2010). Methods: hESC-CM were exposed in-vitro to 15 test compounds, and action potentials (AP) recorded with perforated patch-clamp technique to assess changes in AP duration (APD90) and upstroke velocity (Vmax). The test compounds included: 10 hERG channel, 4 Na+ channel, and 1 IKs channel inhibitors. For comparison purposes, the test compounds were evaluated in the isolated rabbit heart assay (IRH) to determine changes in conduction (QRS) and repolarization (QTc). Potency at hERG, NaV1.5 and IKs channel was also determined. Results: For 7 of 10 hERG channel inhibitors, the potency values across the three functional assays were similar (≤5-fold). Three compounds (dofetilide, sertindole, and terfenadine) showed 10-fold discrepancy between hERG potency and inhibitory concentrations in the hESC-CM and IRH assays. Of the four Na+ channel inhibitors, only mexiletine exhibited similar potency values across the three assays (~3-fold); the others exhibited marked variation (10-fold) in inhibitory potency. No effect on repolarization was observed in hESC-CM treated with a potent IKs blocker, but QTc prolongation was evident in the IRH. Discussion: The functional data indicate that hESC-CM are sensitive for detecting repolarization delay induced by hERG channel blockade, and AP prolongation correlated with potency in the hERG channel and IRH assays. However, hESC-CM were less sensitive for detecting depolarizing delay by Na+ channel blockers, and unable to detect delayed repolarization caused by IKs blockade.
机译:简介:心脏安全性在当代药物开发中至关重要。在新分子药物的研究和开发中,对心脏安全性进行有效而敏感的评估始于临床前体外模型。目前正在评估的新模型是人类胚胎干细胞衍生的心肌细胞(hESC-CM)(Peng,Lacerda,Kirsch,Brown和Bruening-Wright,2010年)。方法:将hESC-CM体外暴露于15种测试化合物,并用穿孔膜片钳技术记录动作电位(AP),以评估AP持续时间(APD90)和上冲程速度(Vmax)的变化。测试化合物包括:10个hERG通道,4个Na +通道和1个IKs通道抑制剂。为了进行比较,在离体兔心脏测定法(IRH)中对测试化合物进行了评估,以确定电导率(QRS)和复极化(QTc)的变化。还确定了在hERG,NaV1.5和IKs通道的效价。结果:对于10种hERG通道抑制剂中的7种,三种功能测定的效价值相似(≤5倍)。在hESC-CM和IRH分析中,三种化合物(多非利特,赛多度和特非那定)在hERG效能和抑制浓度之间显示出> 10倍的差异。在四种Na +通道抑制剂中,只有美西律在三种测定中表现出相似的效价值(约3倍);其他的则显示出抑制力的显着变化(> 10倍)。在用强力IKs阻滞剂治疗的hESC-CM中未观察到对复极化的影响,但在IRH中QTc延长很明显。讨论:功能数据表明,hESC-CM对检测由hERG通道阻滞引起的复极化延迟敏感,并且AP延长与hERG通道和IRH分析的功效相关。然而,hESC-CM对于检测Na +通道阻滞剂的去极化延迟不敏感,并且无法检测到由IK阻滞引起的延迟的去极化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号